This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Compared to Estimates, Kellanova (K) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Kellanova (K) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Kellanova (K) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Kellanova (K) delivered earnings and revenue surprises of 12.20% and 1%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Coty's Q2 Earnings on Deck: Key Factors You Should Understand
by Zacks Equity Research
COTY's Q2 results are likely to reflect the adverse impact of weakness across the Chinese mainland and Asia Travel Retail.
WK Kellogg Gearing Up for Q4 Earnings: What to Expect From KLG Stock?
by Zacks Equity Research
KLG's Q4 results are likely to reflect gains from brand strength and supply-chain enhancements amid cost inflation.
Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPYD
Flowers Foods Gearing Up for Q4 Earnings: What to Expect From FLO?
by Zacks Equity Research
FLO's Q4 results are likely to reflect gains from pricing and brand strength amid cost inflation and a tough consumer landscape.
Ralph Lauren's Brand Momentum to Drive Q3 Earnings: Time to Invest?
by Zacks Equity Research
RL's Q3 results are expected to reflect gains from a strong brand presence, a diverse product portfolio and expanding e-commerce capabilities.
Central Garden & Pet Gears Up for Q1 Earnings: Key Factors to Note
by Zacks Equity Research
CENT's fiscal first-quarter earnings are likely to have shown softness in both Pet and Garden segments due to shifting market dynamics and reduced consumer spending.
Unveiling Kellanova (K) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Kellanova (K) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Kellanova Set to Release Q4 Earnings: Should You Expect a Beat?
by Zacks Equity Research
K's fourth-quarter results are likely to reflect gains from strategic pricing actions and cost-saving efforts.
Kellanova (K) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Kellanova (K) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kellanova (K) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will Kellanova (K) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Kellanova (K) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Kellanova (K) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Kellanova (K) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYD
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Central Garden & Pet Dips 14% in a Month: Solid Bargain or Risky Bet?
by Zacks Equity Research
Technical breakdowns and declining demand spell trouble for CENT. Can it recover?
Here's Why Kellanova (K) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Kellanova (K) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Kellanova (K) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Kellanova (K) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Kellanova (K) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Kellanova (K) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Interparfums (IPAR) Up 8.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Interparfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.